Skip to content
Intact Therapeutics logo

Intact Therapeutics

Intact Therapeutics is a YC Winter 2019 (W19) company. Based in Palo Alto, CA, USA; Los Altos, CA, USA. Team of 4.

  • Drug Delivery
  • Therapeutics

About Intact Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Intact Therapeutics develops smart gel formulations that deliver drugs locally within the gastrointestinal tract, improving absorption at the site of disease. The platform targets GI disorders where systemic drug delivery leaves patients underserved. It replaces conventional oral dosing approaches that distribute drugs broadly rather than concentrating them where they are needed.

From the Y Combinator listing

How Intact Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Smart gels for local drug delivery to the gut

Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
Palo Alto, CA, USA; Los Altos, CA, USA
Team size
4
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works